CVE-2022-26239

{"cve": {"data_type": "CVE", "references": {"reference_data": [{"url": "https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance", "name": "https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance", "tags": ["Product"], "refsource": "MISC"}, {"url": "https://pastebin.com/1QEHrj01", "name": "https://pastebin.com/1QEHrj01", "tags": ["Third Party Advisory"], "refsource": "MISC"}]}, "data_format": "MITRE", "description": {"description_data": [{"lang": "en", "value": "The default privileges for the running service Normand License Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows unprivileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data."}]}, "problemtype": {"problemtype_data": [{"description": [{"lang": "en", "value": "CWE-732"}]}]}, "data_version": "4.0", "CVE_data_meta": {"ID": "CVE-2022-26239", "ASSIGNER": "cve@mitre.org"}}, "impact": {"baseMetricV3": {"cvssV3": {"scope": "UNCHANGED", "version": "3.1", "baseScore": 5.5, "attackVector": "LOCAL", "baseSeverity": "MEDIUM", "vectorString": "CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N", "integrityImpact": "NONE", "userInteraction": "NONE", "attackComplexity": "LOW", "availabilityImpact": "NONE", "privilegesRequired": "LOW", "confidentialityImpact": "HIGH"}, "impactScore": 3.6, "exploitabilityScore": 1.8}}, "publishedDate": "2022-10-06T18:15Z", "configurations": {"nodes": [{"children": [{"children": [], "operator": "OR", "cpe_match": [{"cpe23Uri": "cpe:2.3:a:beckmancoulter:remisol_advance:*:*:*:*:*:*:*:*", "cpe_name": [], "vulnerable": true, "versionEndIncluding": "2.0.12.1"}]}, {"children": [], "operator": "OR", "cpe_match": [{"cpe23Uri": "cpe:2.3:o:microsoft:windows:-:*:*:*:*:*:*:*", "cpe_name": [], "vulnerable": false}]}], "operator": "AND", "cpe_match": []}], "CVE_data_version": "4.0"}, "lastModifiedDate": "2022-10-10T03:00Z"}